BEDFORD, Mass., Nov. 7 Insulet Corporation(Nasdaq: PODD), the manufacturer and marketer of the OmniPod(R) InsulinManagement System, announced plans to release its financial results for thethird quarter 2007 on Wednesday, November 14, 2007 after the close of thefinancial markets.
Insulet will also host a conference call at 8:00 a.m. Eastern Time onThursday, November 15, 2007 to discuss its third quarter 2007 financialresults. During the conference call, material information concerning theCompany, its operations, strategies and prospects may be discussed.
To listen to the conference call, please dial 800.688.0836 for domesticcallers and 617.614.4072 for international callers. The passcode is 63605515.A replay of the conference call will be available two hours after the start ofthe call through December 15, 2007 by dialing 888-286-8010 (domestic) and617-801-6888 (international), passcode 89284526. An online archive of theconference call will also be available by accessing the Investor Informationsection of the company's website at http://investors.insulet.com.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated toimproving the lives of people with diabetes. The Company's OmniPod InsulinManagement System is a revolutionary, discreet and easy-to-use insulininfusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks toexpand the use of continuous subcutaneous insulin infusion (CSII) therapyamong people with insulin-dependent diabetes. Founded in 2000, Insulet isbased in Bedford, MA.Contact: Stephanie Marks for Insulet Corporation [email protected]
SOURCE Insulet Corporation